Wealth Effects’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.9K Buy
+12,512
New +$94.1K 0.03% 232
2025
Q4
Sell
-33,821
Closed -$361K 225
2025
Q3
$361K Sell
33,821
-31,019
-48% -$304K 0.12% 138
2025
Q2
$628K Buy
64,840
+5,736
+10% +$59.2K 0.23% 82
2025
Q1
$880K Buy
59,104
+526
+0.9% +$8.09K 0.37% 59
2024
Q4
$874K Buy
58,578
+7,160
+14% +$117K 0.31% 62
2024
Q3
$984K Buy
51,418
+1,607
+3% +$33.3K 0.34% 60
2024
Q2
$1.03M Sell
49,811
-1,993
-4% -$39.6K 0.37% 53
2024
Q1
$974K Buy
51,804
+5,327
+11% +$91.4K 0.36% 60
2023
Q4
$670K Buy
46,477
+13,843
+42% +$188K 0.25% 91
2023
Q3
$567K Sell
32,634
-5,268
-14% -$110K 0.28% 81
2023
Q2
$789K Sell
37,902
-1,901
-5% -$41.3K 0.35% 63
2023
Q1
$936K Buy
39,803
+4,380
+12% +$118K 0.48% 48
2022
Q4
$989K Buy
35,423
+249
+0.7% +$6.37K 0.56% 40
2022
Q3
$823K Buy
35,174
+4,002
+13% +$121K 0.5% 47
2022
Q2
$1.05M Buy
+31,172
New +$1.09M 0.63% 42
2022
Q1
Sell
-43,827
Closed -$1.33M 218
2021
Q4
$1.33M Buy
+43,827
New +$1.43M 0.55% 41

Other funds holding OGN

Wealth Effects's OGN Position: Q1 2026 in Review

Wealth Effects opened a new position in Organon & Co (OGN) in Q1 2026: 12,512 shares worth $74.9K. The stake represents 0.03% of the portfolio and ranks #232 among its holdings. This is a return to the name: Wealth Effects previously reported a position in OGN as recently as Q3 2025.

Wealth Effects first reported a position in OGN in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.33M in Q4 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Wealth Effects held 12,512 shares of Organon & Co worth $74.9K as of Q1 2026.
  • Organon & Co was a new Wealth Effects position in Q1 2026.
  • Organon & Co made up 0.03% of Wealth Effects's portfolio in Q1 2026, its #232 holding.
  • Wealth Effects first reported a position in Organon & Co in Q4 2021 and has held it in 16 quarters since.
  • Wealth Effects's Organon & Co position peaked at $1.33M in Q4 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.